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Themechanisms bywhich exercise regulates physiological cardiac growth and protects againstmaladaptive
remodeling of the heart have been long sought after. In this issue, Liu et al. (2015) report that microRNAs are
important regulators of exercise responses in the heart.Experimental and clinical studies have
shown that exercise keeps the heart
healthy. Exercise induces many changes
in signaling pathways, which lead to
changes in gene expression networks
that are distinct from the pathophysiolog-
ical response to pressure overload (Dirkx
et al., 2013). Despite the induction of
similar phenotypical changes in the heart
after a short-term induction of exercise,
as opposed to pressure overload, exer-
cise-exposed hearts are protected
against further insults. The hypertrophic
response to exercise is additionally
accompanied by increased expression
of markers of cardiomyocyte proliferation.
Exercise-induced pathways thereby may
be used to identify cardioprotective
signaling pathways that can be mimicked
to therapeutically improve cardiac resis-
tance against stressors.
In this issue of Cell Metabolism, Liu
et al. (2015) conducted a microRNA
(miR) screening to identify differentially
regulated miRs whose expression pro-
files change during exercise, leading to
physiological cardiac growth. miRs are
small non-coding RNAs that control
gene expression by binding to mRNAs,
thereby inhibiting translation or inducing
degradation of the targeted mRNA. Since
miRs target up to hundreds of mRNAs,
they control gene expression networks
rather than single genes. The authors
identified several miRs, including miR-
222, and showed that an inhibition of
miR-222 by anti-miRs prevented the
adaptive response of the heart after
exercise and abolished cardiac and
cardiomyocyte growth as well as exer-
cise-induced increase in cardiomyocyte
proliferation markers. Using prediction
programs combined with bioinformatics
profiling, they were able to identify
several genes with functions that arelinked to the growth and proliferation of
cardiomyocytes, such as p27, Hipk1,
and Hmbox1, as miR-222 targets (Fig-
ure 1). Since exercise-modulated gene
expression networks might protect the
heart from injury and maladaptive remod-
eling, the authors subsequently deter-
mined whether mimicking the response
to exercise by overexpressing miR-222
improves cardiac function and repair in
the heart, after myocardial infarction.
Indeed, mice overexpressing miR-222
were protected against ischemia-induced
cardiac dysfunction and maladaptive
remodeling. These data suggest that
overexpression of miR-222 may repre-
sent a therapeutic cardioprotective strat-
egy. However, some points needs to be
taken into account when considering
this strategy for translation into the
clinic. First, miR-222 must be specifically
overexpressed in cardiomyocytes, as
miR-222 may induce detrimental effects
in other cell types; miR-222 was shown
to impair endothelial cell function by
targeting STAT5 and other protective
pathways (Dentelli et al., 2010), which
may prevent the necessary angiogenic
response after ischemia, if miR-222
is expressed systemically. Second, in
vascular smooth muscle cells, miR-222
can induce proliferation and prevent
apoptosis (Mackenzie et al., 2014);
thereby, miR-222 overexpression may
induce restenosis in the stented coronary
artery. Finally, together with its paralog
miR-221 on the same X chromosome,
miR-222 is upregulated in various forms
of cancers (Garofalo et al., 2012). Taken
together, cardiomyocyte-specific over-
expression of miR-222 appears manda-
tory. The use of adeno-associated virus
(AAV) vectors that specifically target
cardiomyocytes may overcome these
adverse effects.Cell MetabolismIn line with the need for the cell-type-
specific targeting of miR-222, exercise
appears to induce a cell-specific regula-
tion of miR-222. Although miR-222 was
induced in cardiomyocytes, a reduction
(although not statistically significant) was
observed in the non-cardiomyocyte
populations of the heart. These cells
comprise endothelial cells and fibro-
blasts, and one may speculate that the
downregulation of miR-222 in endothelial
cells may contribute to the well-docu-
mented vasculo-protective effects of
exercise. It will be interesting to under-
stand by which mechanisms exercise
induces this counter-regulatory effects
on miR-222 expression in different cell
types. In addition, miR-222 appears also
to have distinct targets in different cells.
Thus, it would be interesting to decipher
why miR-222 does not target cardio-
protective genes in cardiomyocytes. In
endothelial cells, Dentelli et al. (2010)
identified STAT5A as a bona fide target
of miR-222. Previous studies show that
STAT5 is activated in response to
ischemia and reperfusion and that its
inhibition is detrimental (Yamaura et al.,
2003). It might be interesting to see
whether STAT5 expression is indeed not
affected in cardiomyocytes as one would
expect from the protective effects seen
after its overexpression.
One of the intriguing findings of the
study by Liu et al. (2015) is the docu-
mentation of increased proliferation of
cardiomyocytes by miR-222. Cardiomyo-
cyte proliferation majorly contributes
to regeneration of the hearts of model
organisms and neonatal mice. In adult
mammalian hearts, proliferation of cardio-
myocytes is a rare event, but some miRs,
such as miR-15 (Porrello et al., 2013),
miR-199a, and miR-590 (Eulalio et al.,
2012), have previously been shown to21, April 7, 2015 ª2015 Elsevier Inc. 511
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Figure 1. Impact of miR-222 on Cardiomyocytes
Exercise induces the expression of miR-222 in cardiomyocytes. This leads
to cardiomyocyte growth, proliferation, and cardiac repair, by repressing
p27, Hipk1, and Hmbox1.
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Previewsincrease cardiomyocyte pro-
liferation. The demonstra-
tion of proliferation markers
(such as Ki-67 and phos-
pho-histone H3) induced by
overexpression of miR-222
as shown by Liu et al. (2015)
suggests an increased cardi-
omyocyte proliferation, and
the study therefore identi-
fies an additional candidate
miR, which may augment
the regeneration of the heart.
However, documentation of
bona fide cardiomyocyte
cell division is challenging,
and increased proliferation
markers may not necessarily
be associated with cardio-
myocyte cell division. There-
fore, further in depth inves-
tigations are necessary to
confirm that miR-222 indeed
augments cardiac regenera-
tion in addition to repair.
Besides their role in physi-
ological and pathophysiolog-
ical processes, miRs can bestably detected in the circulation and
might be used as biomarkers (Fichtlsch-
erer et al., 2011). Interestingly, an increase
in miR-222 by exercise in the heart, as
shown by Liu et al. (2015), is accompanied
by augmented levels of circulating miR-
222, in healthy volunteers after physiolog-
ical exercise (Baggish et al., 2011). One
may speculate that measurement of
circulating miR-222 might be useful as a
biomarker for physiological rather than
pathophysiological adaptive response.512 Cell Metabolism 21, April 7, 2015 ª2015However, due to the differential regulation
of miR-222 in different cell types, and the
lack of insights into the origin of circu-
lating miR-222, this remains to be further
determined in clinical studies.
Together, the study of Liu et al. (2015)
opens up novel insights into the contribu-
tion of miRs to the physiological response
of the heart. Further studies to elucidate
the therapeutic potential of the identified
miR for cardiac regeneration will be of
particular interest.Elsevier Inc.ACKNOWLEDGMENTS
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